Lilly's Growth in Diabetes and Obesity, and Strong Oncology and Immunology Drugs Create a ...
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
ePlus inc. (NASDAQ:PLUS) Q3 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Welcome to the ePlus Earnings Results Conference Call. As a reminder, this ...
Insider Monkey on MSN15 小时
Accuray Incorporated (NASDAQ:ARAY) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Accuray Fiscal 2025 Second Quarter Financial Results Conference Call. All participants ...